Cite
Verocq C, Decaestecker C, Rocq L, et al. The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: A retrospective study. Oncol Lett. 2020;19(5):3400-3410doi: 10.3892/ol.2020.11458.
Verocq, C., Decaestecker, C., Rocq, L., De Clercq, S., Verrellen, A., Mekinda, Z., Ocak, S., Compère, C., Stanciu-Pop, C., Salmon, I., Remmelink, M., & D'Haene, N. (2020). The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: A retrospective study. Oncology letters, 19(5), 3400-3410. https://doi.org/10.3892/ol.2020.11458
Verocq, Camille, et al. "The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: A retrospective study." Oncology letters vol. 19,5 (2020): 3400-3410. doi: https://doi.org/10.3892/ol.2020.11458
Verocq C, Decaestecker C, Rocq L, De Clercq S, Verrellen A, Mekinda Z, Ocak S, Compère C, Stanciu-Pop C, Salmon I, Remmelink M, D'Haene N. The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: A retrospective study. Oncol Lett. 2020 May;19(5):3400-3410. doi: 10.3892/ol.2020.11458. Epub 2020 Mar 12. PMID: 32269612; PMCID: PMC7115063.
Copy
Download .nbib